TUCSON, AZ / ACCESSWIRE / February 1, 2022 / Aqualung Therapeutics, an early-stage immunotherapeutics biotech company developing an anti-inflammatory therapeutic platform for unchecked inflammation, a characteristic of serious acute diseases; has published a study in Scientific Reports (Tadeo Bermudez lead author) highlighting the effectiveness of the eNAMPT-neutralizing ALT-100 monoclonal antibody (mAb)in reducing Acute Respiratory Distress Syndrome (ARDS)/Ventilator Induced Lung Injury (VILI) symptoms in both rat and porcine animal models.
Continue reading→

University of Arizona startup GenetiRate has been designated one of two companies honored with the Seafood Innovation Award at the North Atlantic Seafood Forum (NASF) 2019. Awarded on March 7, NASF Seafood Innovation Day, the company won the honor for its technology for genetic selection to improve sustainability and production.Continue reading→